Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
| Condition(s) | Opioid-Induced Esophageal Dysfunction |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED). |
| Who can participate | Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin injection within the prior 12 months. * Esophageal stricture * Achalasia types I and II * Allergy to Lidocaine or other local anesthetics * Subjects on anticoagulation * Bilateral nasal obstruction * Pregnancy or breast feeding |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Mayo Clinic |
| Locations | Rochester, Minnesota, United States |
| Start date | 2023-09-18 |
| NCT ID | NCT05854303 |
| Official listing | https://clinicaltrials.gov/study/NCT05854303 |